BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260505T030834
CREATED:20260203T032013Z
LAST-MODIFIED:20260203T032013Z
UID:10000246-1773075600-1773075600@melanoma.org.au
SUMMARY:Rising Tide Clinical Cancer Research Program
DESCRIPTION:RTFCCR invites academic institutions and not-for-profit organizations to collaborate on innovative\, patient-centered clinical trials. Our mission is to improve cancer patients’ treatment options and quality of life by funding studies focused on detection\, treatment\, and implementation. \nWe support phase I to phase III interventional clinical trials but do not fund basic research\, phase IV trials\, or observational studies. Funding is available to institutions worldwide where effective grant oversight is feasible. \nSubmission Criteria \n\nThe interventional clinical trial can be an early—to—late—stage clinical trial (Phase 1\, 2\, and 3) with a patient partner involvement in the study protocol design.\nOnly applications aimed at detecting and intervening in early cancer (pre-cancerous changes) can also be considered at the pre-clinical validation stage.\nPharmaceutical agents used in the study can be generic (off-patent repurposing)\, registered for this indication\, or under development by an academic institution.\nClinical trials testing immunotherapies should be discussed with RTFCCR before application submission.\nFinal selection will be contingent on scientific review\, strategic portfolio fit\, and availability of funds\n\nKey Dates \nApplication deadlines: 9 March\, 22 June and 23 November 2026 \nSEE FUNDING GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/rising-tide-research-program/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/RisingTide600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260306T235900
DTEND;TZID=Australia/Sydney:20260306T235900
DTSTAMP:20260505T030834
CREATED:20260211T233409Z
LAST-MODIFIED:20260211T233409Z
UID:10000254-1772841540-1772841540@melanoma.org.au
SUMMARY:CPC Catchlove Sylvan Mid-Career Researcher Fellowship
DESCRIPTION:Applications for the Charles Perkins Centre Catchlove Sylvan Mid-Career Researcher Fellowship 2026 are now open. Inaugurated in 2025\, this bridging support scheme is designed to help our best mid-career researchers remain in academia. \nThe Fellowship is made possible with generous support from our long-time friends\, philanthropists\, Dr Barry Catchlove and Professor Louise Sylvan. In its inaugural year\, the scheme supported three of our brightest mid-career researchers. \nIn 2026\, up to three awards\, with a maximum value of $100\,000 each\, will be available for Charles Perkins Centre mid-career researchers. \nKey Dates \nApplications close: Friday 6 March 2026 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/cpc-catchlove-fellowship/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Charles_Perkins_Centre-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260302T170000
DTEND;TZID=Australia/Sydney:20260302T170000
DTSTAMP:20260505T030834
CREATED:20260203T032740Z
LAST-MODIFIED:20260203T032740Z
UID:10000245-1772470800-1772470800@melanoma.org.au
SUMMARY:CRI Postdoctoral Fellowships
DESCRIPTION:CRI Irvington and CRI Immuno-Informatics Postdoctoral Fellowship Program  \nThe CRI Irvington Postdoctoral Fellowship Program is one of the most prestigious training opportunities in immunology and cancer immunology. It supports outstanding young researchers at the world’s leading universities and research institutions\, providing the resources\, mentorship\, and professional development needed to launch independent scientific careers at the forefront of discovery. \nThe CRI Immuno-Informatics Postdoctoral Fellowship Program supports outstanding early-career scientists worldwide who seek dual expertise in immunology and data science. This unique program fosters a new generation of researchers fluent in both biology and computation\, equipping them to drive innovation in cancer immunotherapy. \nFellowships provide three years of support\, including a stipend of $74\,000\, $76\,000\, and $78\,000 in years 1-3. The host institution receives a $5\,000 annual allowance for use at the sponsor’s discretion to cover costs such as research supplies\, conference travel\, health insurance\, or childcare. CRI also provides dedicated support for fellows to attend the CRI Bioinformatics Bootcamp. Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. \nKey Dates \nApplication deadlines: 2 March and 1 September 2026 \nSEE CRI IRVINGTON GUIDELINESSEE CRI IMMUNO-INFORMATICS GUIDELINES
URL:https://melanoma.org.au/event/cri-postdoc-fellowships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/CRI-PostDoc-Fellow-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260227T170000
DTEND;TZID=Australia/Sydney:20260227T170000
DTSTAMP:20260505T030834
CREATED:20260211T024951Z
LAST-MODIFIED:20260211T024951Z
UID:10000252-1772211600-1772211600@melanoma.org.au
SUMMARY:Sydney Cancer Partners Conference & Travel Funding
DESCRIPTION:SCP has limited funding available to support members presenting research results at a national or international conference. \nThis scheme aims to: \n\nSupport the professional development and expand the knowledge of SCP members.\nBuild interest and expertise in translational cancer research and evidence based clinical practice.\nDisseminate knowledge and information through the SCP website and other events.\n\nSuccessful applicants will receive up to: \n\n$1\,000 to present in person at a conference within Australia.\n$4\,000 to present in person at an international conference.\n$500 for registration fees to present at a virtual conference.\n\nFunding for in-person events can be used for registration fees\, travel\, and reasonable accommodation expenses. Per diem and meal reimbursement is not a claimable expense. Awardees are required to submit original invoices or receipts for reimbursement. \nFunding for virtual conferences is limited to the registration fee. \nKey Dates \nRound 16: 1 April – 30 June 2026. Applications close 5pm\, 27 February 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/scp-conference-travel-funding/
CATEGORIES:Grants,Travel
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Sydney_Cancer_Partners600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260227T170000
DTEND;TZID=Australia/Sydney:20260227T170000
DTSTAMP:20260505T030834
CREATED:20251202T040717Z
LAST-MODIFIED:20251202T042314Z
UID:10000222-1772211600-1772211600@melanoma.org.au
SUMMARY:Sally Crossing AM Award for an Outstanding Outcome in Cancer Research
DESCRIPTION:This Award is dedicated to the memory of the late Sally Crossing AM (1946-2016). Sally was a pioneer and tireless advocate for consumer involvement in cancer research. Cancer Council NSW and Cancer Voices NSW acknowledge the extraordinary support of the Belalberi Foundation and the Crossing family in conferring this award. \nThe Sally Crossing AM Award for an Outstanding Outcome in Cancer Research (individual award) rewards outstanding achievement in cancer research\, the inclusion of consumers in research\, and the delivery of significant benefit to the cancer community. \nThe Award recipient will receive $75\,000 to further their research endeavours. \nKey Dates\nApplications close: Friday 27 February 2026\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/sally-crossing-award/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/CC-Sally-Crossing.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251211T170000
DTEND;TZID=Australia/Sydney:20251211T170000
DTSTAMP:20260505T030834
CREATED:20251202T032647Z
LAST-MODIFIED:20251202T032844Z
UID:10000220-1765472400-1765472400@melanoma.org.au
SUMMARY:MRFF 2025 Research Data Infrastructure Grant
DESCRIPTION:This grant opportunity is part of the Medical Research Future Fund and the Research Data Infrastructure Initiative. It looks to fund the creation or extension of national research data infrastructure to support world-class health and medical research in Australia. \nThe objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need. \nKey Dates\nApplications close: Thursday 11 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2025-data-infrastructure-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/MRFF.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251205T170000
DTEND;TZID=Australia/Sydney:20251205T170000
DTSTAMP:20260505T030834
CREATED:20251118T004913Z
LAST-MODIFIED:20251203T015911Z
UID:10000211-1764954000-1764954000@melanoma.org.au
SUMMARY:Perpetual Impact Grant
DESCRIPTION:The Perpetual IMPACT Philanthropy Application program creates meaningful connections between philanthropists and Not-for-Profit (NFP) organisations. It provides a platform for NFP’s to showcase how they deliver improved outcomes for the communities they serve. \nThe grant supports high-quality\, sustainable impact by identifying organisations that demonstrate strong governance\, capable leadership\, strategic clarity\, and a clear focus on measurable outcomes. \nKey Dates\nApplications open: Monday 27 October 2025\, 9.00am AEDT\nApplications close: Friday 5 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-impact-grant/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/Perpetual-1.png
END:VEVENT
END:VCALENDAR